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Oral vaccination using attenuated and recombinant rabies vaccines has been proven a powerful tool to combat rabies in wildlife. However, clear differences have been observed in vaccine titers needed to induce a protective immune response against rabies after oral vaccination in different reservoir species. The mechanisms contributing to the observed resistance against oral rabies vaccination in some species are not completely understood. Hence, the immunogenicity of the vaccine virus strain, SPBN GASGAS, was investigated in a species considered to be susceptible to oral rabies vaccination (red fox) and a species refractory to this route of administration (striped skunk). Additionally, the dissemination of the vaccine virus in the oral cavity was analyzed for these two species. It was shown that the palatine tonsils play a critical role in vaccine virus uptake. Main differences could be observed in palatine tonsil infection between both species, revealing a locally restricted dissemination of infected cells in foxes. The absence of virus infected cells in palatine tonsils of skunks suggests a less efficient uptake of or infection by vaccine virus which may lead to a reduced response to oral vaccination. Understanding the mechanisms of oral resistance to rabies virus vaccine absorption and primary replication may lead to the development of novel strategies to enhance vaccine efficacy in problematic species like the striped skunk. Ó 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Oral vaccination against rabies using modified live rabies virus vaccines has been highly successful in different reservoir species. The first animal targeted was the red fox (Vulpes vulpes) followed by the raccoon dog (Nyctereutes procyonoides) [1, 2] . Subsequently, the concept of oral rabies baiting was investigated for other animal species, like raccoons (Procyon lotor) [3, 4] , coyotes (Canis latrans) [5] [6] [7] , gray foxes (Urocyon cineroargenteus), striped skunks (Mephitis mephitis) [8] , small Indian mongooses (Herpestes auropunctatus) [9, 10] , and domestic dogs (Canis lupus domesticus) [11] [12] [13] .
It became evident that not all animal species were equally susceptible for vaccination by the oral route; some species like the striped skunk seem to be extremely refractory to oral rabies vaccination, irrespective of the construct used even when high virus titres were administered [4, [14] [15] [16] [17] [18] [19] [20] . Oral virus vaccines for veterinary use, e.g. rabies [21] [22] [23] [24] [25] [26] [27] [28] and classical swine fever (CFS) virus [29] [30] [31] [32] or recombinant poxvirus against lethal plaque [33] [34] [35] have been developed and used under field conditions in Europe and North America. However, it remains largely unknown how and where the vaccine viruses are transported across the epithelium in the oral cavity.
Several studies have revealed that the vaccine viruses are predominantly present in the tonsils and less pronounced in the oral mucosal epithelium after oral administration as shown for both attenuated and recombinant oral rabies virus vaccines [36] [37] [38] [39] [40] [41] as well as for attenuated CFS vaccine virus constructs [42] [43] [44] . Lymphoreticular tissues of the pharynx assumed to be involved in efficient oral immunization, also called Waldeyer's tonsillar ring, variably comprise Tonsilla (T.) lingualis, T. palatina, T. veli palatini, T. paraepiglottica, T. pharyngea, and T. tubaria in a speciesdependent pattern. Furthermore, tonsils can be subdivided based on their histoarchitecture into those containing epithelial crypts or those covered by a smooth epithelium as well as those bulging above the mucosal surface versus those covered within a mucosal fossa [45] [46] [47] [48] . Because of this complexity, the exact locations of entry of the attenuated rabies virus vaccines within these tissues and the pharmacokinetics have not been investigated in detail. Hence, even after 35 years of oral vaccination of wildlife against rabies there is limited knowledge on how oral vaccination in target species actually works. Considering the difficulties in inducing a protective immune response against rabies in reservoir species other than foxes and raccoon dogs, prompted us to elucidate the mechanisms behind. Therefore, the objectives of this study were to (i) examine the immunogenicity of an oral rabies virus vaccine construct in two species that show extreme differences in susceptibility to oral vaccination; the red fox (Vulpes vulpes) and striped skunk (Mephitis mephitis), after direct oral administration, and (ii) investigate the dissemination of the vaccine virus construct in the oral cavity of these two species by establishing the hypothesis that differences in virus presence and replication in lymphoreticular tissues, in particular the palatine tonsils between the two species could contribute to the vaccine uptake efficiency.
Material and methods

Vaccine virus
The SPBN GASGAS vaccine virus was constructed as previously described [49] . The parental vaccine of SPBN GASGAS is the SAD B19 oral rabies vaccine virus. The SPBN construct lacks the pseudogene (w) and the G-gene is flanked by a Sma/XmaI and PacIrestriction enzyme cleavage site. Furthermore, the SPBN-virus contains a linker to express a (foreign) gene with two restriction enzyme sites (BsiWhI/NheI) for subsequent introduction of additional genetic information. The construct contains two glycoprotein genes with the following two modifications (site-directed mutagenesis); a change from asparagine to serine and one from arginine to glutamic acid at position 194 and 333 of the glycoprotein, respectively [49, 50] . The antigen, SPBN GASGAS was produced according to the protocol given by Vos et al. [51] . Antigen with titers >10 8.0 focus forming units (FFU)/ml was concentrated via tangential flow filtration using ultrafiltration flat sheet cassettes with a Molecular Weight Cut Off (MWCO) of 300 kDa.
Animals
A total of 14 and 4 foxes and 24 and 4 striped skunks were used for the vaccination and challenge and dissemination studies, respectively. All foxes and striped skunks used in this study were obtained from different commercial sources in Poland and the United States, respectively. Foxes were kept in individual cages during the entire observation period. Meanwhile, skunks were partially kept in small groups, if applicable, until challenge infection. All animals were sedated (mixture of 1.1 mg/kg Xylazin and 2 mg/kg Ketamin) during vaccine administration and challenge infection.
Ethics statement
All in vivo work was performed at IDT Biologika GmbH, according to European guidelines on animal welfare and care pursuant to the Federation of European Laboratory Animal Science Associations (FELASA). Study protocols were evaluated and approved by the responsible authorities (Landesverwaltungsamt Sachsen -Anhalt, Referat Verbraucherschutz, Veterinärangelegenheiten) in the federal state of Saxony-Anhalt, Germany; AZ42502-3-670 IDT (red fox -immunogenicity study), AZ 42505-3-669 IDT (striped skunk and red fox -dissemination study), AZ 42505-3-582 IDT (striped skunk -immunogenicity study).
Vaccination and challenge studies
To determine the minimum effective dose of SPBN GASGAS in striped skunks, different doses were administered by direct oral administration; 10 7.3 FFU/ml (n = 3), 10 8.0 FFU/ml (n = 5) and 10 9.2 FFU/ml (n = 6). To mimic natural conditions, 1.5 ml (foxes) and 1 ml (skunks) of virus suspension was directly administered into the oral cavity but not targeted directly to the tonsils. Also, two skunks received the highest dose intra muscularly (i.m.). For foxes, a similar minimum effective dose as determined with the oral rabies vaccine strain SAD B19 was applied [52] . Hence, here only a single low dose of SPBN GASGAS (10 6.5 FFU/ml) by direct oral instillation was tested in 6 animals. The vaccinated animals were inoculated with a challenge virus (10 5.1 MICLD50) between days 42 and 98 post vaccination together with control animals (N = 8). The challenge virus used was isolated from the salivary glands of a red fox (2nd passage) infected experimentally with an isolate from a naturally infected coyote (CVS/ USA/TX Coyote/295/R/061893 -Centers for Disease Control and Prevention, Atlanta, USA).
Dissemination studies
For dissemination studies in each case four foxes and skunks were kept individually in groups of 2 animals each in an isolation unit within the Animal House at IDT. All animals received 1.0 ml SPBN GASGAS (10 7.5 FFU/ml) by direct oral instillation. Two animals of each species were euthanized at day 3 and 5 post vaccine administration. During necropsy different tissues (tonsils [Tonsilla palatina, T. pharyngealis], Supplementary Fig. 1 ), tongue, regional lymph nodes [Lymphonodi (Lnn.) parotidei, Lnn. retropharyngei, Lnn. mandibulares] and mucous membrane of the upper and lower oral cavity) were collected and examined for the presence of rabies virus vaccine construct by RT-PCR and RTCIT. Saliva samples were collected prior to vaccine administration (S0) and 1 h (S1), 2 h (S2), 3 h (S3), 24 h (S4), 48 h (S5), 72 h (S6), if applicable, 120 h (S7) post vaccine administration. Saliva swabs were collected by swabbing of the oral cavity for 1-1.5 min. Subsequently, the cotton tips were placed in 2 ml MEM medium supplemented with antibiotics (gentamycin [50 mg/l] and amphotericin [2.5 mg/l]) and stored at À80°C until further investigation using RT-PCR and RTCIT.
Diagnostic assays
Different regions of the brain, i.e. hippocampus, medulla oblongata and cerebellum, of animals challenged with street RABV were tested for the presence of viral antigen using the direct ImmunoFluorescence Test (dIFT) [53] . For detection of SPBN GASGAS specific viral RNA in lymphopharyngeal tissues as well as in saliva swabs of foxes and skunks obtained during dissemination studies, RNA was extracted with TRIzol (Invitrogen)/TRIfast Ò (PEQLAB Biotechnologie GmbH, Erlangen, Germany) according to manufacturers' recommendations, followed by real-time RT-PCR (qRT-PCR) essentially as described [54] . The presence of viable rabies virus particles in qRT-PCR positive tissues was confirmed with the rabies tissue culture infection test (RTCIT) [55, 56] [58] . VNA titres were defined as the dilution of test sera showing a 50% reduction of the test virus (50% neutralizing dose, ND50) and were calculated using inverse interpolation. Subsequently, VNA titres were compared to the titre of the reference serum [2nd WHO Standard for Rabies Immunoglobulin (Human) (National Institute for Biological Standards and Controls, NIBSC, Potters Bar, Hertfordshire, UK] and converted to IU/ml.
Palatine tonsils of red foxes and skunks were collected at necropsy immediately after euthanasia and fixed in 4% neutralbuffered formaldehyde. For immunocytochemical analysis, vibratome sections with a thickness of 100 mm were prepared and stained with a specific antibody against RABV N protein (polyclonal rabbit-a-RABV N 161-5, 1:5000 diluted in PBS) in combination with Alexa Fluor Ò 568 goat-a-rabbit secondary antibody (ThermoFisher Scientific, 0.7 mg/ml). For visualization of nuclei, Hoechst 33342 (ThermoFisher Scientific, 1 mg/ml) was used. The stained palatine tonsil sections were examined by confocal laser scanning microscopy (Leica SP5 confocal laser scan microscope, Microsystems, Germany). Images were processed with the ImageJ software version 1.48b [59] .
Results
Seroconversion and protection against RABV require higher infectious SPBN GASGAS vaccine doses in striped skunk than in red fox
In order to assess whether increased immunogenicity of SPBN GASGAS virus, as observed in mouse [49] , raccoon [60] and dog [13] These data showed that similar to previous oral live vaccines the immunogenicity of SPBN GASGAS at lower doses is limited in skunks and that those limitations can be overcome partially by application of almost 1000x higher vaccine virus doses than required for efficient red fox immunization. In contrast to direct oral administration of SPBN GASGAS, two skunks that received 10 9.2 FFU vaccine virus by the intramuscular (i.m.) route of infection developed high levels of rabies VNAs with 47.5 IU/ml both at day 28 post vaccination. All control foxes and striped skunks succumbed to the challenge infection as confirmed by dIFT. These data confirmed that requirement for vaccine virus doses was not a result of low immunogenicity of SPBN GASGAS in skunks in general but more likely represents unknown host specific constraints for oral vaccination route.
Dissemination of SPBN GASGAS in the oropharynx differs in skunks and foxes
As the low immunogenicity of SPBN GASGAS relied on the oral administration route and restriction in the immunization process could be at least partially overcome by increased infectious virus titers, we hypothesized that dissemination of the oral rabies vaccine virus in the oropharynx and infection of particular target cells or tissues is a determinant for vaccination efficacy. Therefore, dissemination of SPBN GASGAS in the oropharynx of 4 skunks and 4 foxes after oral vaccination with 10 7.5 FFU vaccine virus/animal was investigated. With 10 7.5 FFU a virus dose was chosen that was one log above the 100% protective doses in red foxes and still two logs below protective doses in skunks (Table 1) . For both, vaccinated skunks and foxes, virus detection in saliva swabs by RT-PCR was only possible within the first 3 h after direct vaccine administration (Table 2) , with exception of one skunk specimen taken at day 1 after vaccination. Interestingly, none of the PCR positive saliva specimens from foxes was positive for viable virus detection by RTCIT, whereas 6 out of 12 saliva specimens from skunks were RTCIT positive. Detection of more infectious virus in skunks than in foxes within the first 3 h after vaccination indicated, that rapid virus inactivation by unknown skunk specific factors was not responsible for the low immunogenicity of the live virus vaccine. Notably, with the exception of one PCR positive saliva specimen from skunks at day 1 (24 h p.i.), neither in foxes nor in skunks positive saliva samples were detected at 24 h, 48 h, 72 h, and 96 h after vaccine administration, showing that no or very low virus amounts that remained below detection levels were shed into the saliva of immunized animals. Lack of virus in the saliva at 24 h to 96 h post vaccine administration raised the question whether vaccine virus did not efficiently infect cells in the oropharynx of both, fox and skunk, or whether dissemination in different organ tissues still occurred. Therefore, dissemination of the virus was followed by RT-PCR detection in organ tissues taken after day 3 and 5 post vaccination from 2 animals per host species and time point. Rabies virus RNA was detected in 10 tissue samples from foxes including mucosa, lymph nodes, tongue and tonsils (Table 3) . Notably, viable virus detection by RTCIT was only possible from the Tonsilla palatina at day 2 (both foxes) and day 3 (one of two foxes) post vaccination, indicating that the main site of vaccine virus replication is located in the Tonsilla palatina.
In striking contrast, RT-PCR screening for virus RNA in skunks was negative in most tissues (Table 3) . Only one PCR positive tongue sample at day 5 post infection and two positive tonsils (one Tonsilla palatina at days 3 and 5, respectively) indicated that virus infection of screened tissues in the oropharynx was less efficient in skunks than in foxes. However, virus isolation from the RT-PCR positive skunk tonsil at day 3 showed that vaccine virus infection occurs in skunks, but obviously on a much lower level.
Vaccine virus infection is restricted to peripheral areas of the palatine tonsils
As palatine tonsils were identified as a most reliable replication site for SPBN GASGAS with presence of infectious virus even at days 3 and 5 post vaccination, the tropism of SPBN GASGAS in tonsil tissues from foxes was further investigated by immunofluorescence analysis of 100 mm thick vibratome slices stained with RABV specific antibodies. At day 3 post vaccination, foci of infected cells were detected in peripheral areas of the tonsils (Fig. 1A) . Blue nuclei staining further indicated that the foci were restricted to the outer epithelium cell layer and were excluded from subepithelial and inner-/extra-follicular regions. Comparable distribution of SPBN GASGAS in the palatine tonsil of the second fox (not shown) indicated that the observed focal infection pattern in peripheral epithelium was characteristic for vaccine virus infection at day 3 after oral administration.
Analysis of fox tonsils at day 5 post infection ( Fig. 1B) revealed loss of most infection foci at the epithelial region. Only single cells or smaller sized foci could be detected by immunofluorescence against RABV N protein. Similar to day 3, no infected cells were detected in inner tonsil areas of lymphoid follicles and extrafollicular regions. These data show that virus infected cells are largely removed from tonsil tissues until day 5 post infection.
Discussion
All available oral rabies vaccines are based on replicationcompetent viruses. It seems that for the induction of a protective long-lasting immune response, primary virus replication is needed. Due to the instability of the rabies virus, the gastro-intestinal tract will cause rapid antigen degradation. Hence the rabies virus vaccine must be taken up in the oral cavity for the development of an immune response. The first animal species targeted for oral vaccination against rabies was the red fox and coincidentally a relative low dose was required to induce protective immunity. However, the efficacy of oral rabies virus vaccines constructs like SPBN GAS-GAS is much less pronounced in other species like skunks [61] , which was confirmed by our efficacy study. Only when an extreme high number of virus particles were administered, a detectable and protective immune response could be achieved in skunks (Table 1) . The different time points of challenge chosen for foxes and skunks post vaccination in our studies are unlikely to have an influence on the outcome of the study as the immune response after oral vaccination with attenuated rabies virus vaccines was shown to be fully developed within 3-4 weeks [52, 62, 63] . Because the studies had a pilot character, the number of animals had to be kept to a minimum to follow the 3Rs principles. Therefore, our results could not be statistically evaluated for significance. However, the differences are in agreement with other published studies. This less 
pronounced efficacy does not seem to be restricted to this particular construct or other rabies virus vaccines but a more general observation, irrespective of the used virus backbone [14] [15] [16] [17] [18] [19] [20] . An exception could be a recombinant canine adenovirus 2 (CAV2) construct expressing the rabies virus glycoprotein. Almost all skunks that received a relatively low dose of this construct (10 7.0 TCID50) by direct oral administration seroconverted and were protected against a challenge infection [61] . However, pre-existing immunity against CAV2 has been shown to interfere with vaccination success [64] . This lack of efficacy seems to be associated specifically with the oral route of administration because skunks developed consistent high levels of rabies virus neutralizing antibodies when the vaccine construct SPBN GASGAS was administered intramuscularly (i.m.). Also, when vaccinated with an inactivated commercial rabies vaccine, striped skunks developed a typical rabies VNA response as observed in other carnivores [65] . To proof whether requirement for vaccine virus doses is not a result of low immunogenicity of SPBN GASGAS in skunks in general but more likely represents unknown host specific constraints for oral vaccination route, dissemination studies were conducted. The results showed, that using the same dose, vaccine absorption in oral cavity was much less pronounced in striped skunks than in red foxes (Table 3 ), which could be a possible explanation why skunks are extremely refractory to oral vaccination against rabies. Uptake by the oral route may also be influenced by the duration of exposure in the oral cavity, for example as a result of high saliva secretion and flow that may dilute the antigen or lead to swallowing of the antigen before it is absorbed [66, 67] . However, it was actually shown that viable virus in the oral cavity is much longer detectable in the saliva of skunks than in foxes (Table 2) . Possibly, a very early infection of lymphoreticular tissues of the oropharynx is decisive for subsequent vaccine efficacy, which suggests that those tissues of foxes are more susceptible regardless of the quick inactivation of viable vaccine virus. This might explain why none of the PCR positive saliva specimens from foxes, even with a relatively low ct-value, was positive for viable virus detection by RTCIT (Table 2) . Therefore, it can also be excluded that potential viral inhibitory factors (microbial peptides, pH) in the oral cavity of skunks play a role in the reduced vaccine absorption. Considering the natural predominant route of rabies transmission, whereby the virus loaded saliva of an infected animal is transmitted during a biting incident, the presence of antimicrobial peptides and proteins in the oral cavity of skunks acting as rabies virus inhibitors, seems unlikely. However, the presence of salivary inhibitors including acidic proline-richproteins, albumins, lactoferrin, mucins and salivary agglutinins that may block cell binding and fusion through interaction in the saliva of skunks has not been investigated and can therefore not be excluded. Like for oral CSF vaccine virus constructs [42] [43] [44] the results of this study confirm previous studies that identified the palatine tonsils as the primary site of rabies vaccine virus uptake compared to the oral mucosal epithelium [39] [40] [41] , although rabies vaccine virus was isolated on some occasion from the oral mucosa in this and other studies [40] . Direct virus vaccine transport across the oral mucosa is possible though (1) transcytosis through epithelial cells, (2) epithelial transmigration of infected donor cells, or (3) uptake during physical breaches. The latter mechanism can be excluded, as an artificial disruption of the oral mucosa epithelial barrier in skunks, providing the vaccine virus a direct access to the mucosal microcirculation prior to direct oral RABV vaccine administration, did not improve the immune response (unpublished results). The palatine tonsils as primary site for vaccine uptake seem evident, since the tonsils are a major component of the mucosaassociated lymphoid tissue (MALT) [68, 69] .
It remains to be resolved, why rabies virus vaccine uptake is relatively inefficient in skunks compared to other animal species like foxes. The demonstration of a comparable anatomic configuration of Waldeyer's tonsillar ring with a dominating palatine tonsil [45, 47] , as well as the histologic confirmation that it represents a crypt-free tonsil covered within its mucosal fossa in both, red foxes and skunks ( Supplementary Fig. 1 ), suggests that the morphology of the lymphoreticular tissue of the pharynx cannot explain the observed difference in vaccine uptake.
Hence, further studies will have to focus on vaccine virus entry and replication in the palatine tonsils of different reservoir species. For this purpose, in vivo tracking studies should be conducted to identify the main target cells of virus entry in the palatine tonsils. It is claimed that the covering epithelium of the palatine tonsils is unsuitable for antigen uptake and that specialized cells similar to M-cells of the Peyers' patches play an important role [70] . Understanding the mechanisms of antigen uptake, transport and initial replication may lead to concepts improving rabies virus vaccine uptake in reservoir species, refractory to the oral route of vaccine administration and to improved vaccine formulation containing potent and safe mucosal adjuvants or mucoadhesives [67, 71] .
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